PHARMACEUTICALS BIOPHARMACEUTICAL PRODUCTS

Brand	Owner	Address	Description
NONAKINE	GRYPHON THERAPEUTICS, INC.	250 East Grand Avenue, Suite 90 South San Francisco CA 94080	Pharmaceuticals and biopharmaceutical products, namely, for the treatment of HIV, AIDS, inflammation, immune disfunction, Kaposi Sarcoma, secondary infections associated with HIV and AIDS, and hematopoietic deficiency; diagnostic reagents and chemical compounds for medical use;Reagents and chemical compounds for scientific use and scientific laboratory use; reagents and chemical compounds for scientific and medical research use;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Disclosed is a process wherein a first olefin selected from certain ?,?-dihydroxyalkenes and 4-(alkenyl)ethylenecarbonates is reacted with a second olefin reactant to produce an olefin metathesis product. When the first olefin reactant is an optically enriched or enantiomerically pure ?,?-dihydroxyalkene, cross metathesis reactions produce products possessing the same optical purity. The ?,?-dihydroxyalkenes and the 4-(alkenyl)ethylene carbonates may be converted to hydrogenated products, and the 4-(alkenyl)ethylenecarbonates may be decarboxylated to provide the corresponding epoxides. The products of the disclosure may be used as monomers for the preparation of specialty polyesters and as intermediates in the manufacture pharmaceuticals and other chemicals.